+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Brain Cancer Drugs Market Research Reports

Meningioma - Pipeline Insight, 2024 - Product Thumbnail Image

Meningioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
Brain Cancer - Pipeline Insight, 2024 - Product Thumbnail Image

Brain Cancer - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Gliosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Gliosarcoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Pediatric Brain Tumors - Pipeline Insight, 2024 - Product Thumbnail Image

Pediatric Brain Tumors - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Astrocytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Astrocytoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Ependymoma - Pipeline Insight, 2024 - Product Thumbnail Image

Ependymoma - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 60 Pages
  • Global
From
Neurofibrosarcoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neurofibrosarcoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 120 Pages
  • Global
From
Recurrent Malignant Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent Malignant Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Diffuse Intrinsic Pontine Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Glioblastoma multiforme (GBM) - Pipeline Insight, 2024 - Product Thumbnail Image

Glioblastoma multiforme (GBM) - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Glioma - Pipeline Insight, 2024 - Product Thumbnail Image

Glioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 450 Pages
  • Global
From
Pediatric Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Pediatric Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Recurrent Glioblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Recurrent Glioblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 200 Pages
  • Global
From
Neuroblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Neuroblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Medulloblastoma - Pipeline Insight, 2024 - Product Thumbnail Image

Medulloblastoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Oligodendroglioma - Pipeline Insight, 2024 - Product Thumbnail Image

Oligodendroglioma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 60 Pages
  • Global
From
Anaplastic astrocytoma - Pipeline Insight, 2024 - Product Thumbnail Image

Anaplastic astrocytoma - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 85 Pages
  • Global
From
From
From
From
Loading Indicator

The Brain Cancer Drugs market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs used to treat brain cancer. Brain cancer is a type of cancer that affects the cells of the brain and can be caused by a variety of factors, including genetics, environmental exposure, and lifestyle. Brain cancer drugs are used to treat the symptoms of brain cancer, such as headaches, seizures, and nausea, as well as to slow the progression of the disease. Brain cancer drugs are typically divided into two categories: chemotherapy and targeted therapy. Chemotherapy drugs are used to kill cancer cells, while targeted therapy drugs are designed to target specific cancer cells and stop them from growing. Both types of drugs are used in combination to treat brain cancer. Some of the major companies in the Brain Cancer Drugs market include Bristol-Myers Squibb, Merck, Pfizer, Novartis, and Roche. These companies are involved in the development and sale of drugs used to treat brain cancer, as well as in the research and development of new treatments. Show Less Read more